Position in ALNY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$780,871
+$439,414 QoQ
Shares Held
2,594
+151.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#422
of 764 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026denkapparat Operations GmbH holds $12,101,957 across 21 Biotechnology names. ALNY ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
17,890 | $2,028,010 | |
| 2 | EXEL |
Exelixis, Inc.
|
33,152 | $1,803,800 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,566 | $976,463 | |
| 4 | ARGX |
Argenx SE
|
910 | $844,270 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,594 | $780,871 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
11,938 | $683,092 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
8,364 | $663,181 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
21,324 | $639,293 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $780,871 | 2,594 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $341,457 | 1,032 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $362,656 | 912 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||